Microbial protein and membrane targets

Microbial protein and membrane targets represent a broad classification of molecular structures within pathogens, such as bacteria and fungi, that are exploited for therapeutic intervention. These targets include essential enzymes like penicillin-binding proteins (PBPs) involved in cell wall synthesis, ribosomes responsible for protein translation, and the physical integrity of the microbial lipid bilayer (Kohanski et al., 2010, Nature Reviews Microbiology). Therapeutic agents like beta-lactams, glycopeptides, and polymyxins exert their effects by binding to these specific proteins or disrupting lipid bilayers, leading to cell lysis or growth inhibition (StatPearls, 2023, Antibiotics). Because this term refers to a broad category of distinct molecular entities rather than a single receptor or enzyme, it is classified as a non-specific target group in drug discovery. Understanding the interaction between drugs and these microbial components is critical for overcoming antimicrobial resistance and developing narrow-spectrum therapies (NIH, 2022, Antimicrobial Agents). This category is central to the treatment of various infectious diseases, though it presents challenges regarding host toxicity and the preservation of the commensal microbiome (PubMed, 2021, PMC7273310).

Other names

Antimicrobial targetsBacterial cell wall and membrane proteinsPathogen-specific targetsMicrobial targets

Inhibition of cell wall synthesis, disruption of membrane potential and integrity, and inhibition of essential metabolic enzymes or protein synthesis.